Product Information

MEXILETINE 200 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2627 per EA under NDC 64980066701. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Aug 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEXILETINE 200 MG CAPSULE

Mexiletine Hydrochloride
$0.2627per EA

Strength

200 mg/1

NDC

64980066701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MEXILETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215315

FDA Approved

8/26/2022

TE Code

AB

On Market Since

2/5/2025

Pharmacological Classes

Price Statistics

The NADAC for MEXILETINE 200 MG CAPSULE has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 16.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2627 per EA
All-time high$0.3155 (Sep 10, 2025)
All-time low$0.2570 (Jul 22, 2026)
52-week high$0.3155
52-week low$0.2570
Median price$0.2813
Average price$0.2823
Largest weekly change-7.4% (May 20, 2026)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

+2.2%

1M

+2.2%

3M

-3.2%

6M

-11.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

-16.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MEXILETINE 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 200 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2627 per EA (NDC 64980066701), effective Aug 19, 2026.

How has the price of MEXILETINE 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MEXILETINE 200 MG CAPSULE has declined 16.7%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for MEXILETINE 200 MG CAPSULE?

Since Aug 27, 2025, the NADAC for MEXILETINE 200 MG CAPSULE has ranged from a low of $0.2570 (Jul 22, 2026) to a high of $0.3155 (Sep 10, 2025), with a median of $0.2813 per EA.

Are there cheaper alternatives to MEXILETINE 200 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEXILETINE 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures MEXILETINE 200 MG CAPSULE?

MEXILETINE 200 MG CAPSULE (NDC 64980066701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.